Your Twin learns with you

30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Jean-François Cavalier

Senior researcher (CRCN)

CNRS Délégation Provence et Corse
Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (12)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

The development of new and effective antimicrobial compounds is urgent due to the emergence of resistant bacteria. Natural plant flavonoids are known to be effective molecules, but their activity and selectivity have to be increased. Based on previous aurone potency, we designed new aurone derivatives bearing acetamido and amino groups at the position 5 of the A ring and managing various monosubstitutions at the B ring. A series of 31 new aurone derivatives were first evaluated for their antimicrobial activity with five derivatives being the most active (compounds 10, 12, 15, 16, and 20). The evaluation of their cytotoxicity on human cells and of their therapeutic index (TI) showed that compounds 10 and 20 had the highest TI. Finally, screening against a large panel of pathogens confirmed that compounds 10 and 20 possess large spectrum antimicrobial activity, including on bioweapon BSL3 strains, with MIC values as low as 0.78 µM. These results demonstrate that 5-acetamidoaurones are far more active and safer compared with 5-aminoaurones, and that benzyloxy and isopropyl substitutions at the B ring are the most promising strategy in the exploration of new antimicrobial aurones.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (17)

Magali Casanova

Aix-Marseille University

FRANCE
View details

Maxime Robin

Aix-Marseille University

FRANCE
View details

Jean Michel Brunel

Aix-Marseille University

FRANCE
View details

Victoria Magrioti

Associate Professor

National and Kapodistrian University of Athens

GREECE
View details

Paweł Bakun

Doctor, Head of the Pharmaceutical Nanotechnology Laboratory at PUMS

Poznan University of Medical Sciences

POLAND
View details

Mickael Lafond

-

FRANCE
View details

Marek Murias

professor

Poznan University of Medical Sciences

POLAND
View details

Céline Crauste

Université de Montpellier

FRANCE
View details

Jean Michel Bolla

Head of Laboratory

INSERM

FRANCE
View details

Vadim Shlyonsky

Université libre de Bruxelles (ULB)

BELGIUM
View details

Stephane Canaan

CNRS Délégation Provence et Corse

FRANCE
View details

Vincent LE MOIGNE

Université de Versailles Saint-Quentin-en-Yvelines

FRANCE
View details

Marc Maresca

Maitre de conférence

Aix-Marseille University

FRANCE
View details

Jordan Lehoux

University of Otago

NEW ZEALAND
View details

Priscille Brodin

Research Director

INSERM

FRANCE
View details

Laurent Kremer

Head of team "Mycobacterial Pathogenesis and Novel Therapeutic Targets

University of Montpellier

FRANCE
View details

Werner Kaminsky

X-Ray Crystallographer

University of Washington

UNITED STATES
View details